Pediatric Lymphomatoid Papulosis “Type E” Exclusively Involving the Oral Mucosa: Case Report and Review of the Literature
Authors:
- Karina Helen MartinsKMKarina Helen Martins
- Heitor Albergoni SilveiraHSHeitor Albergoni Silveira
- Edith Lara-CarrilloEdith Lara-Carrillo
- María Fernanda Lara-FonsecaMLMaría Fernanda Lara-Fonseca
- Victor Hugo Toral-RizoVTVictor Hugo Toral-Rizo
- Fernando ChahudFCFernando Chahud
- Jorge Esquiche LeónJLJorge Esquiche León
- 4 February 2026
- journal article
- review article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 48 (4) , 267-270
Abstract
Lymphomatoid papulosis (LyP) type E is a rare form of primary cutaneous CD30 + lymphoproliferative disorder characterized by recurrent ulcerative lesions on the skin and/or mucous membranes, after a course of remissions and relapses; however, it is a localized disease with a good prognosis. We have previously reported 2 cases of LyP types C and D with exclusively intraoral involvement. To date, 32 cases of intraoral LyP have been reported. Of them, only 3 cases were diagnosed as LyP type E. We report a 17-year-old Mexican female patient who developed multiple intraoral lesions, without skin or other mucosal surface involvement, with episodes of remission and exacerbation. Histopathologic analysis revealed infiltrates of small-to-medium-sized atypical lymphoid cells, with foci of angiocentric and angioinvasive pattern. By immunohistochemistry, the atypical lymphoid cells were positive for CD3, CD5, CD7 (partial loss), and CD8. Unlike TCRD, TCRBF1 highlighted numerous atypical lymphoid cells, which were also CD30, granzyme B, perforin, TIA-1, and MUM1 positive, and whose angiocentric and angioinvasive pattern was evidenced through CD34 and α-SMA markers. EBER1/2 was negative, with Ki-67 highlighting most atypical lymphoid cells. Treatment with topical corticosteroids has provided considerable improvements, showing resolution of lesions. To the best of our knowledge, this is the first case of LyP type E affecting a pediatric patient with lesions confined to the oral mucosa.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/11419-0; 2022/07479-9 and 2022/12760-9)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (304241/2021-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 14 references indexed in Scilit:
- Intraoral Lymphomatoid Papulosis Type D Showing Scarce/Absent CD30 Expression in A Pediatric Patient: Case Report and Literature ReviewHead and Neck Pathology, 2025
- Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and ImmunohistochemicallyHead and Neck Pathology, 2024
- Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)British Journal of Dermatology, 2024
- Lymphomatoid Papulosis “Type E” Affecting the Palate: A Detailed Case Report and Review of LiteratureThe American Journal of Dermatopathology, 2023
- Oral manifestation of lymphomatoid papulosis: systematic reviewJournal of Oral Medicine and Oral Surgery, 2022
- Epstein-Barr Virus–Positive Mucocutaneous Ulcer Mimicking Peri-Implantitis in a Patient With Systemic Lupus ErythematosusJournal of Oral and Maxillofacial Surgery, 2019
- Lymphomatoid papulosis type E with a CD56+ immunophenotype presenting with purpura‐like lesionsJournal of Cutaneous Pathology, 2019
- Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphomaAnnals of Diagnostic Pathology, 2017
- Angioinvasive Lymphomatoid PapulosisAmerican Journal of Surgical Pathology, 2013
- Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patientsJournal of the American Academy of Dermatology, 2009